Overexpression of interleukin-13 induces minimal-change-like nephropathy in rats
about
Pathogenesis of minimal change nephrotic syndrome: an immunological conceptUpdate on the treatment of focal segmental glomerulosclerosis in renal transplantationNew insights into human minimal change disease: lessons from animal modelsInvariant natural killer T cell agonist modulates experimental focal and segmental glomerulosclerosisTreatment with IFN-{alpha}, -{beta}, or -{gamma} is associated with collapsing focal segmental glomerulosclerosis.Idiopathic nephrotic syndrome and atopy: is there a common link?A higher frequency of CD4⁺CXCR5⁺ T follicular helper cells in adult patients with minimal change disease.Pathogenesis, diagnosis and management of paraneoplastic glomerulonephritisToll-like receptor 3 ligand, polyIC, induces proteinuria and glomerular CD80, and increases urinary CD80 in mice.Effects of interleukin-13 and montelukast on the expression of zonula occludens-1 in human podocytesNephrotic syndrome in children: from bench to treatmentPodocyte biology for the bedsideEffects of gluten-free, dairy-free diet on childhood nephrotic syndrome and gut microbiotaGlomerular Immune Deposits Are Predictive of Poor Long-Term Outcome in Patients with Adult Biopsy-Proven Minimal Change Disease: A Cohort Study in KoreaProteinuria predicts relapse in adolescent and adult minimal change disease.DNA methylation changes between relapse and remission of minimal change nephrotic syndromeTLR-mediated albuminuria needs TNFα-mediated cooperativity between TLRs present in hematopoietic tissues and CD80 present on non-hematopoietic tissues in mice.Serum from minimal change patients in relapse increases CD80 expression in cultured podocytes.Urinary CD80 excretion increases in idiopathic minimal-change diseaseLupus podocytopathy: An important differential diagnosis of nephrotic syndrome in systemic lupus erythematosus.Immune and inflammatory role in renal disease.T regulatory cell function in idiopathic minimal lesion nephrotic syndrome.Recent advances in understanding and treating nephrotic syndrome.A conceptual framework for the molecular pathogenesis of progressive kidney disease.Immunopathogenesis of idiopathic nephrotic syndrome with relapse.Childhood nephrotic syndrome--current and future therapies.The role of the immune system in idiopathic nephrotic syndrome: a review of clinical and experimental studies.De novo membrano-proliferative nephritis following interferon therapy for chronic hepatitis C (case study and literature review).Renal biopsy: use of biomarkers as a tool for the diagnosis of focal segmental glomerulosclerosis.Role of basophils in the pathogenesis of minimal change nephrotic syndrome: A literature review.Permeability factors in idiopathic nephrotic syndrome: historical perspectives and lessons for the future.Onco-nephrology: current concepts and future perspectives.The experimental model of nephrotic syndrome induced by Doxorubicin in rodents: an update.Pathogenesis of childhood idiopathic nephrotic syndrome: a paradigm shift from T-cells to podocytes.The glomerular permeability factors in idiopathic nephrotic syndrome.Kidney diseases associated with haematological cancers.Regulatory T cells and minimal change nephropathy: in the midst of a complex network.Rituximab in Minimal Change Disease: Mechanisms of Action and Hypotheses for Future Studies.Pathogenesis of proteinuria in idiopathic minimal change disease: molecular mechanisms.Increased risk of idiopathic nephrotic syndrome in children with atopic dermatitis.
P2860
Q26747387-45F847D7-23F5-4240-956C-8544DFFAEFFFQ26751470-FF49F9DD-13F1-4B61-9A1E-D7F3ACC1F339Q26853392-5D07DB46-023E-4900-998F-CFA2FB20787BQ27308115-EE8AF53C-2A5C-4ECD-89F1-CC3C754520E6Q33769962-6DF927B5-1958-4B80-8771-ECD243DCC294Q33956641-9FD8A9A2-2B04-4A2C-81B6-199ADB9A5D2DQ34177446-8F00FDD2-2BB3-45D5-A0A2-4E968DC50B19Q34684475-A4B1A62F-0C04-4D83-B6A6-475224137B00Q35055369-1FC926F3-CB35-4484-A2D2-224028F9C085Q35086071-F64E56F8-F5A7-45A1-A33F-086858264817Q35185376-A2BD3E7D-2C7F-454D-9C7E-04017CACED22Q35256633-B65A6E93-B638-46FD-9F32-75DEC3BB12C7Q35327301-003B141C-BB01-4385-BED4-E3414C82ED43Q35901410-D18C4837-ECD1-4F0C-B07D-094ECAA93CACQ36371221-FEF93D15-D666-4D88-82F5-98EF6153F359Q36377508-2E3D1AC7-DEBF-4175-930A-E3A8338B2CEEQ37036149-A53F2434-2D9C-4A79-A12B-D10FEE6E37ABQ37046037-DA15A358-E04E-481C-81F2-C0231CF6E019Q37086660-C4DEDE9C-CD1E-4801-B3D1-6120E668F74CQ37135122-B7C58B94-3E97-466D-A55B-F4B1A5247335Q37243199-BBA55501-1914-48EC-9FE9-BA8BE8884CA1Q37445929-E6D95EA3-860D-484B-B10C-89396A82CC99Q37635783-9E629F86-8C67-425F-8193-CF911E9EEB1BQ37721284-B7D2BDE8-50DA-48C9-94AE-15F45E17AB00Q37742644-1958C27B-FDC8-475A-B81A-4E5FED71A81EQ38017937-A8AD7633-72CE-4548-9F86-27D235D7F7B4Q38152259-2C3E89B2-CD5B-44D3-B889-8F030EB05747Q38169598-21709C47-2FF7-4F7F-BC59-441842335F01Q38203501-6D29B46F-E52A-4C8D-885F-2C5597D386E1Q38246016-C1EA9F18-9E64-4FEA-ABDA-97792D15E252Q38270521-5ECCCE9B-730F-442A-8758-459CC72BFCF6Q38382457-0ABD99C9-B654-4229-892B-7C0B3F5FD797Q38383524-DF5C6103-30E3-4E46-AFDA-8A5D28031684Q38395906-0570FCD8-508E-4832-95E5-A62D8AC1B166Q38449629-911FB94D-53E6-43A0-BFB9-A3E1405F3F27Q38513113-A3240AC3-D344-4298-BA57-5A865A978F3FQ38543132-FC5711F8-019F-45FB-B076-53EDC04B0BE0Q38679589-C93431A7-691B-469A-8300-3024A91CA418Q38844709-985B2E69-19CB-4592-AE83-BFDBB713D8D8Q40208176-B750258E-529B-41C8-957B-7FFFF348B6E7
P2860
Overexpression of interleukin-13 induces minimal-change-like nephropathy in rats
description
2007 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մայիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2007
@ast
scientific journal article
@en
vedecký článok (publikovaný 2007/05/01)
@sk
vědecký článek publikovaný v roce 2007
@cs
wetenschappelijk artikel (gepubliceerd op 2007/05/01)
@nl
наукова стаття, опублікована в травні 2007
@uk
مقالة علمية (نشرت في مايو 2007)
@ar
name
Overexpression of interleukin-13 induces minimal-change-like nephropathy in rats
@ast
Overexpression of interleukin-13 induces minimal-change-like nephropathy in rats
@en
Overexpression of interleukin-13 induces minimal-change-like nephropathy in rats
@nl
type
label
Overexpression of interleukin-13 induces minimal-change-like nephropathy in rats
@ast
Overexpression of interleukin-13 induces minimal-change-like nephropathy in rats
@en
Overexpression of interleukin-13 induces minimal-change-like nephropathy in rats
@nl
prefLabel
Overexpression of interleukin-13 induces minimal-change-like nephropathy in rats
@ast
Overexpression of interleukin-13 induces minimal-change-like nephropathy in rats
@en
Overexpression of interleukin-13 induces minimal-change-like nephropathy in rats
@nl
P2093
P3181
P356
P1476
Overexpression of interleukin-13 induces minimal-change-like nephropathy in rats
@en
P2093
Caroline G. L. Lee
Chang-Li Wei
Gilbert S. C. Chiang
Hui-Kim Yap
Kin-Wai Lai
Li-Kiang Tan
Puay-Hoon Tan
Stanley C. Jordan
P304
P3181
P356
10.1681/ASN.2006070710
P577
2007-05-01T00:00:00Z